Marinomed Biotech
Austria - KorneuburgBiotechnology
Focus: Marinomed Biotech is a small Austrian biotech specializing in seaweed-derived polymer treatments across infectious diseases, ophthalmology, and respiratory conditions. The company operates as a public entity with fewer than 50 employees, positioning itself as a niche player in natural product-based therapeutics.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Employees
1-50
Open Jobs
0
About Marinomed Biotech
AI assessmentNot HiringNo open roles listed right now. Follow Marinomed Biotech to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Carragelose
Stable
Growth
Lead asset addressing two distinct indications (dry eye and respiratory viral infection); multiple clinical trials indicate development priority.
Coldamaris lozenges
Help build intelligence for Marinomed Biotech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.